Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,550.00
-60.00 (-2.30%)
At close: Jun 10, 2026

Chevron Lubricants Lanka Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
23,76424,39312,30610,05323,60935,074
Short-Term Investments
----39075,000
Trading Asset Securities
26,33827,24026,013-75,07514,861
Cash & Short-Term Investments
50,10251,63338,31910,05399,074124,935
Cash Growth
-18.38%34.75%281.15%-89.85%-20.70%-39.08%
Accounts Receivable
14,81415,66316,60714,80717,76912,825
Other Receivables
4,7565,3441,6821,8284,2568,259
Receivables
41,36047,93022,97223,37382,060215,755
Inventory
56,15051,60152,28648,12852,31310,420
Prepaid Expenses
-726.67895.052,490558.1410.67
Other Current Assets
4,3332,638729.2812.786,6042,354
Total Current Assets
151,945154,529115,20084,857240,608353,474
Property, Plant & Equipment
318,243322,533321,458318,212323,77318,857
Long-Term Investments
35,14138,92091,994137,64757,79384,232
Other Intangible Assets
4,9565,2775,1166,2416,4582,796
Long-Term Accounts Receivable
-----20,577
Long-Term Deferred Tax Assets
----662.84755.7
Other Long-Term Assets
24,27924,9363,6763,79310,0999,229
Total Assets
576,991586,993590,984589,397684,140614,621
Accounts Payable
9,4443,0731,9961,3333,809652.59
Accrued Expenses
5,0175,0003,7563,7474,9681,201
Short-Term Debt
169,799167,612103,630129,360134,2632,162
Current Portion of Long-Term Debt
2,000-----
Current Portion of Leases
2,4782,5092,1911,360345.5199.49
Current Income Taxes Payable
----4.18273.93
Current Unearned Revenue
-----119.99
Other Current Liabilities
37,90250,93935,93622,13817,7164,840
Total Current Liabilities
226,640229,133147,509157,938161,1069,449
Long-Term Debt
38,00040,00032,00032,000--
Long-Term Leases
14,87818,67516,19718,277129.06120
Pension & Post-Retirement Benefits
10,10310,50610,2457,7327,5645,600
Long-Term Deferred Tax Liabilities
5,6015,6013,8742,9323,1081,093
Other Long-Term Liabilities
8,9215,5102,4701,8271,8231,178
Total Liabilities
304,144309,426212,294220,705173,73017,440
Common Stock
99,20499,20499,204332,877292,877199,288
Additional Paid-In Capital
704,331704,331704,331358,030335,850327,715
Retained Earnings
-413,851-409,280-239,199-133,310-8,085-21,115
Treasury Stock
-4,485-4,485-4,485-4,463-41.27-41.27
Comprehensive Income & Other
-181,511-182,014-181,360-184,443-194,0792,092
Total Common Equity
203,688207,757378,491368,691426,521507,939
Minority Interest
69,15969,810199.28-83,89089,242
Shareholders' Equity
272,847277,567378,691368,691510,411597,181
Total Liabilities & Equity
576,991586,993590,984589,397684,140614,621
Total Debt
227,155228,796154,017180,997134,7382,481
Net Cash (Debt)
-177,053-177,163-115,698-170,944-35,664122,454
Net Cash Growth
------39.41%
Net Cash Per Share
-14174.84-13450.44-13803.94-40646.99-13234.7846085.02
Filing Date Shares Outstanding
13.1713.1713.174.383.92.66
Total Common Shares Outstanding
13.1713.1713.174.383.92.66
Working Capital
-74,696-74,604-32,308-73,08179,502344,025
Book Value Per Share
15464.3115773.2128735.5884108.18109224.47191160.18
Tangible Book Value
198,733202,480373,376362,451420,063505,142
Tangible Book Value Per Share
15088.0515372.5928347.1982684.48107570.66190107.77
Land
38,46138,46129,66425,15628,3159,313
Buildings
79,909102,32897,59997,507101,3789,647
Machinery
152,240225,657179,320118,620145,73810,258
Construction In Progress
31,03130,97564,463108,99690,433-